Stocks
DermTech, Inc.DMTK
NASDAQHealthcareBiotechnology$0.09-11.32%
Focused on genomic skin cancer diagnostics, the company develops non‑invasive adhesive patch tests designed to detect melanoma and other skin conditions without surgical biopsy. Its flagship technology analyzes gene expression from skin samples collected through a patch, targeting dermatology practi...
Market Cap: $3.3M52W Range: $0.04 – $3.90
This page tracks all publicly disclosed congressional trades in DermTech, Inc. (DMTK), a company in the Healthcare sector. All data is sourced from STOCK Act Periodic Transaction Reports filed with the House and Senate disclosure offices.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Congressional Trading History
No congressional trades found for this stock.